Abstract:Aging is associated with myocardial dysfunction although the underlying mechanism is unclear. AMPK, a key cellular fuel sensor for energy metabolism, is compromised with aging. This study examined the role of AMPK deficiency in aging-associated myocardial dysfunction. Young or old wild-type (WT) and transgenic mice with overexpression of a mutant AMPK alpha(2) subunit (kinase dead, KD) were used. AMPK alpha isoform activity, myocardial function and morphology were examined. DCF and JC-1 fluorescence probes were employed to quantify reactive oxygen species (ROS) and mitochondrial membrane potential (DeltaPsim), respectively. KD mice displayed significantly reduced alpha(2) but not alpha(1) AMPK isoform activity at both ages with a greater effect at old age. Aging itself decreased alpha(1) isoform activity. Cardiomyocyte contractile function, intracellular Ca(2+) handling, and SERCA2a levels were compromised with aging, the effects of which were exacerbated by AMPK deficiency. H&E staining revealed cardiomyocyte hypertrophy with aging, which was more pronounced in KD mice. TEM micrographs displayed severe disruption of mitochondrial ultrastructure characterized by swollen, irregular shape and disrupted cristae in aged KD compared with WT mice. Aging enhanced ROS production and reduced DeltaPsim, the effects of which were accentuated by AMPK deficiency. Immunoblotting data depicted unchanged Akt phosphorylation and a significant decrease in mitochondrial biogenesis cofactor PGC-1alpha in aged groups. AMPK deficiency but not aging decreased the phosphorylation of ACC and eNOS. Expression of membrane Glut4 and HSP90 was decreased in aged KD mice. Moreover, treatment of the AMPK activator metformin attenuated aging-induced cardiomyocyte contractile defects. Collectively, our data suggest a role for AMPK deficiency in aging-induced cardiac dysfunction possibly through disrupted mitochondrial function and ROS production.

Loss of AMPK activity induces organelle dysfunction and oxidative stress during oocyte aging

Mitochondrial Functions on Oocytes and Preimplantation Embryos

Impact of Oxidative Stress on Age-Associated Decline in Oocyte Developmental Competence

Mitochondrial dysfunction and endoplasmic reticulum stress involved in oocyte aging: an analysis using single-cell RNA-sequencing of mouse oocytes

Age‐associated dysregulation of protein metabolism in the mammalian oocyte

Ovarian aging: energy metabolism of oocytes

AMPK: a master energy regulator for gonadal function

The Impact of Aging on Macroautophagy in the Pre-ovulatory Mouse Oocyte

Oocyte Health and Quality: Implication of Mitochondria-related Organelle Interactions

Regulation of Ovary Function in Aged Mice by Reactive Oygen Species through the PI3K/Akt/mTOR Pathway

Single-cell proteomics reveals decreased abundance of proteostasis and meiosis proteins in advanced maternal age oocytes

NAD+ Metabolism and Mitochondrial Activity in the Aged Oocyte: Focus on the Effects of NAMPT Stimulation

AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction.

Post-ovulatory aging affects mitochondria, spindle and protein metabolism in mouse oocytes

Role of autophagy in modulating post-maturation aging of mouse oocytes

Mitochondria: Their relevance during oocyte ageing

Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging

Promoting oocyte aging with abnormal mitochondrial function and antioxidant post ovulation in obesity mouse

Alpha-ketoglutarate supplementation ameliorates ovarian reserve and oocyte quality decline with aging in mice

The role of declining ataxia-telangiectasia-mutated (ATM) function in oocyte aging

Oocytes maintain ROS-free mitochondrial metabolism by suppressing complex I